Lafadofensine is the monoamines reuptake inhibitor . Lafadofensine has th sufficient effects after short-term administration (extracted from patent WO2006121218A1, compound 1).
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Monoamine Oxidase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.